Adocia SAS receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Adocia (ADOC)
Track today's live Adocia (ADOC) share price, performance and key data on this page with our current Paris:ADOC stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Adocia share price on the Paris exchange. Use the dropdown to switch exchange for the ADOC share price, head to our technical summary section, which provides analysis on Adocia share price buy/sell indicators using real-time data (or discuss the Adocia (ADOC) stock price today with other investors in the Adocia EPA share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current EPA:ADOC share price (ISIN: FR0011184241) to enhance your trading decisions with our free investment tools and resources.
What Is the Adocia Share Price Today?
The Adocia share price today is 2.45.
What Is the Stock Symbol for Adocia
The stock symbol (or 'ticker') for Adocia is "ADOC."
What Stock Exchange Does Adocia Trade On?
Adocia is listed and trades on the Paris stock exchange.
Is Adocia a Good Stock to Buy?
Determining whether Adocia (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current EPA:ADOC share price (ISIN: FR0011184241) to enhance your trading decisions with our free investment tools and resources.
What Is the Adocia Share Price Today?
The Adocia share price today is 2.45.
What Is the Stock Symbol for Adocia
The stock symbol (or 'ticker') for Adocia is "ADOC."
What Stock Exchange Does Adocia Trade On?
Adocia is listed and trades on the Paris stock exchange.
Is Adocia a Good Stock to Buy?
Determining whether Adocia (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
2.45
+0.17(+7.48%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.15
2.46
52 wk Range
2.01
9.76
Earnings results expected in 8 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.152.46
52 wk Range
2.019.76
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ADOC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
9.70
Upside
+295.92%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
Adocia SAS receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Adocia SAS receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 9.70
(+295.92% Upside)
Earnings
Latest Release
24/09/2026
EPS / Forecast
-0.44 / -0.58
Revenue / Forecast
43K / --
Compare ADOC to Peers and Sector
Metrics to compare | ADOC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipADOCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.1x | −2.8x | −0.3x | |
PEG Ratio | 0.08 | −0.03 | 0.00 | |
Price/Book | −10.7x | 0.9x | 2.6x | |
Price / LTM Sales | 16.4x | 5.8x | 2.9x | |
Upside (Analyst Target) | 295.9% | 302.4% | 64.0% | |
Fair Value Upside | Unlock | −5.5% | 7.8% | Unlock |
Adocia SA, a clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity. The company’s proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company provides BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid prandial insulin lispro; BioChaperone GLP-1 Amylin, a combination of acting insulin glargine and rapid-acting insulin lispro, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity, including AdoShell Islets, an ultra rapid insulin; AdOral Sema, an oral form of GLP-1 semaglutide; and AdoXLongSem, a long-lasting injectable formulation of semaglutide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Adocia (Paris: ADOC) Share Price Today?
The Adocia stock price today is 2.45 EUR.
What Stock Exchange Does Adocia (ADOC) Trade On?
Adocia is listed and trades on the Paris Stock Exchange.
What Is the Ticker (Stock Symbol) for Adocia?
The stock symbol (also called a 'ticker') for Adocia is "ADOC."
What Is the Current Adocia Market Capitalisation?
As of today, Adocia (Paris: ADOC) market cap is 48.94M EUR.
What Is Adocia's (ADOC) Earnings Per Share (TTM)?
The Adocia EPS is currently -0.83 (Trailing Twelve Months).
When Is the Next Adocia Earnings Date?
Adocia's next earnings report will be released on 29/10/2026.
Is ADOC a Buy or Sell From a Technical Analyst Perspective?
Based on today's Adocia moving averages and other technical indicators, the daily buy/sell signal for ADOC stock is Neutral.
How Many Times Has Adocia Stock Split?
Adocia has split 0 times. (See the ADOC stock split history page for full effective split date and price information.)
How Many Employees Does Adocia Have?
Adocia has 80 employees, based on their latest Companies House report.
What is the current trading status of Adocia (Paris: ADOC)?
As of 21/10/2026, Adocia (ADOC) is trading at a share price of 2.45 EUR, with a previous close of 2.45 EUR. The stock has fluctuated within a day range of 2.15 EUR to 2.46 EUR, while its 52-week range spans from 2.01 EUR to 9.76 EUR.
What Is Adocia (ADOC) Price Target According to Analysts?
The average 12-month price target for Adocia is 9.70 EUR, with a high estimate of 12 EUR and a low estimate of 4.8 EUR. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +295.92% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.